Improving the heart team: An interdisciplinary team and integrated practice unit

Veronese, Elinthon Tavares; Pomerantzeff, Pablo Maria Alberto; Jatene, Fábio Biscegli

doi:10.4330/wjc.v13.i12.650

Cited by 2 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 3 Alternatively, Tremblay et al 38 found that patients with cancer under the care of teams working with a greater interdisciplinary intensity reported four times greater access to care compared with lower intensity teams; access which our participants reported as a major difficulty. Furthermore, Veronese et al 39 found improvements in surgery waiting times through interdisciplinary teamwork even when factoring in socioeconomic barriers in upper-middle-income countries. Therefore, facilitating access through a ‘buffet-style’ approach in an interdisciplinary manner should ensure greater access to, and equity of, care.…”

Section: Discussionmentioning

confidence: 99%

Lived experience of patients with Long COVID: a qualitative study in the UK

et al. 2023

View full text Add to dashboard Cite

BackgroundLong COVID is a rapidly evolving global health crisis requiring interdisciplinary support strategies that incorporate the lived experience of patients. Currently, there is a paucity of research documenting the day-to-day experiences of patients living with Long COVID.ObjectiveTo explore the lived experience of Long COVID patients.Study designLongitudinal, observation study.SettingAn inductive, data-driven, qualitative approach was used to evaluate hand-written diaries obtained from individuals who had been referred to a Derbyshire Long COVID clinic.Participants12 participants (11 females, age 49±10 years, 11 Caucasians) were recruited. Participants were included if they had a previous confirmed or suspected COVID-19 infection with ongoing recovery, >18 years old, understood the study requirements and provided informed consent.MethodParticipants were directed to complete self-report diaries over 16 weeks. Responses were transcribed verbatim and analysed using thematic analysis.ResultsThree key themes were highlighted: (1) understanding who helps patients manage symptoms, (2) daily activities and the impact on quality of life and health status and (3) the effect of turbulent and episodic symptom profiles on personal identity and recovery.ConclusionsThe novel challenges presented by Long COVID are complex with varying inter-related factors that are broadly impacting functional status and quality of life. Support mechanisms must incorporate the lived experiences and foster true collaborations between health professionals, patients and researchers to improve patient outcomes.Trial registration numberNCT04649957.

show abstract

Section: Discussionmentioning

confidence: 99%

Lived experience of patients with Long COVID: a qualitative study in the UK

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Even with increasing research into the nuances of different patient populations, there are limitations to applying trial-derived recommendations to real-world scenarios. Clinical trials abide by strict eligibility criteria that challenge the generalizability of their findings, with half to three-quarters of all real-world patients meeting clinical criteria that would make them ineligible for enrolment in contemporary trials [38,39] . This is one of many benefits of a Heart Team approach, as it interprets multidisciplinary evidence in the context of the patient's unique clinical profile to facilitate shared decision-making and personalized care [40] .…”

Section: Treatment Of Cad With Reduced Lvefmentioning

confidence: 99%

Disparities in therapies for coronary artery disease with reduced left ventricular ejection fraction

Ghunaim,

Vervoort,

Elfaki

et al. 2023

Vessel Plus

View full text Add to dashboard Cite

Revascularization through percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is used to manage left ventricular systolic dysfunction (LVSD) due to coronary artery disease (CAD). This review provides an overview of coronary revascularization for CAD with reduced left ventricular ejection fraction (LVEF), focusing on disparities in management. CABG provides more complete revascularization, and lower long-term all-cause mortality and reintervention and MI rates compared to PCI in patients with LVSD and CAD. Consequently, CABG is recommended as the primary revascularization therapy for CAD with reduced LVEF, with PCI being reserved for patients who are high-risk or have unfavorable coronary anatomy. Although LVSD increases revascularization risk, differential outcomes can be attributed to patients’ biological, behavioral, and socioeconomic factors as well as health system deficiencies. Women and racially and/or ethnically minoritized patients often present with progressive disease and greater comorbidity, experience delays in diagnosis and treatment, and have higher morbidity and mortality rates post-revascularization. These disparities may be explained by biological differences compounded by social determinants of health. Patients with CAD with LVSD pose unique medical challenges, which may be further complicated by disparities in care. Increased representation of minoritized patients in cardiovascular trials is needed to elucidate these differences and their long-term impact.

show abstract

Improving the heart team: An interdisciplinary team and integrated practice unit

Cited by 2 publications

References 30 publications

Lived experience of patients with Long COVID: a qualitative study in the UK

Lived experience of patients with Long COVID: a qualitative study in the UK

Disparities in therapies for coronary artery disease with reduced left ventricular ejection fraction

Contact Info

Product

Resources

About